Evidence map›Paper›PMID 39570842›Full record

ArticlePloS one2024

Drug-related problems among type 2 diabetic patients in Sunwal Municipality of Western Nepal.

Sushma Chapagain, Nabin Pathak, Kushal Subedi, Prakash Ghimire, Bijay Adhikari, Niranjan Shrestha, Nim Bahadur Dangi

Abstract read
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sushma ChapagainPharmaceutical Sciences Program, Faculty of Health Sciences, School of Health and Allied Sciences, Pokhara University, Pokhara, Kaski, Nepal.ORCID 0000-0002-4735-1380
Nabin PathakDrug Information Unit and Pharmacovigilance Cell, Hospital Pharmacy Department, Hetauda Hospital, Madan Bhandari Academy of Health Sciences, Hetauda, Makwanpur, Bagmati Province, Nepal.ORCID 0000-0002-1952-642X
Kushal SubediPokhara University Teaching Hospital, Pokhara, Kaski, Nepal.ORCID 0000-0003-2136-8499
Prakash GhimireUniversal College of Medical Sciences, Bhairahawa, Rupandehi, Nepal.
Bijay AdhikariPharmaceutical Sciences Program, Faculty of Health Sciences, School of Health and Allied Sciences, Pokhara University, Pokhara, Kaski, Nepal.
Niranjan ShresthaPharmaceutical Sciences Program, Faculty of Health Sciences, School of Health and Allied Sciences, Pokhara University, Pokhara, Kaski, Nepal.
Nim Bahadur DangiPharmaceutical Sciences Program, Faculty of Health Sciences, School of Health and Allied Sciences, Pokhara University, Pokhara, Kaski, Nepal.ORCID 0000-0003-1501-9196

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSeveral diseases co-exist with diabetes such as hypertension, and dyslipidemia, leading to cases of non-adherence, several drug interactions, and an increased risk of adverse drug reactions among patients, which are often termed as drug-related problems (DRPs). The role of pharmacists in high-income countries is well-defined in identifying DRPs among type 2 diabetes patients. However, these roles still need to be explored within low- and middle-income countries. The study aimed to identify DRPs in Type 2 diabetic patients.

methodsA community-based cross-sectional study was conducted in the Sunwal Municipality, Lumbini Province, Nepal from April to November 2021 where a stratified random sampling technique was employed to collect the data. The study included patients aged ≥ 18 years of either gender with type 2 diabetes who were prescribed at least one anti-diabetic medication. Patients were visited at their homes once identified through the community pharmacies, and a prescription review was conducted to identify the DRPs by using the Pharmaceutical Care Network Europe (PCNE) V8.02 tool and pertinent guidelines.

resultsAmong 182 patients, 97 (53.3%) had DRPs. Most of the patients were 50-60 years (n = 46; 25.3%), with a mean ± SD age of 55.43±14.46, as most were female (n = 94; 51.6%). Biguanides and sulfonylureas were the common classes of drugs prescribed. The major class of drug associated with DRPs were biguanides (n = 85; 49.7%), followed by sulfonylureas (n = 42; 24.6%). Metformin was the major drug associated with DRPs (n = 85; 49.4%). The major type of DRP identified was treatment effectiveness (n = 82; 79.61%), while patients not adhering to drug therapy (n = 97; 71.85%) was the leading cause of DRPs. DRPs were significantly associated with the duration of diabetes (p = .007) and the number of fruit servings (p = .007).

conclusionThe majority of the patients were found to have DRPs. The visiting patients at home by the pharmacists helped in identifying the DRPs and associated factors among type 2 diabetes patients, which may aid in the prevention and management of the disease.

Indexed as

Diabetes Mellitus, Type 2Hypoglycemic AgentsAdultAgedCross-Sectional StudiesDrug-Related Side Effects and Adverse ReactionsFemaleHumansMaleMiddle AgedNepalPharmacistsHypoglycemic Agents

Identifiers

PMID39570842
PMCPMC11581294

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.